Soleil Raises PT on Stryker (SYK) from $82 to $86
Tweet
Share
E-mailGet Alerts SYK Hot Sheet
Price: $320.85 -0.91%
Rating Summary:
33 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
33 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Soleil Securities Group raises its price target on Stryker (NYSE: SYK) from $82 to $86 and maintains a Buy rating.
The firm notes Stryker's Q1 EPS of $0.70 as in-line; Soleil also mentions that Stryker holds about $5.61 per share in cash. Furthermore, Soleil believes Stryker's analyst meeting on May 8 will be upbeat.
Notably, Soleil's $86 price target on Stryker represents potential upside of about 34% from yesterday's closing price of $63.95.
Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. [BCS]
The firm notes Stryker's Q1 EPS of $0.70 as in-line; Soleil also mentions that Stryker holds about $5.61 per share in cash. Furthermore, Soleil believes Stryker's analyst meeting on May 8 will be upbeat.
Notably, Soleil's $86 price target on Stryker represents potential upside of about 34% from yesterday's closing price of $63.95.
Stryker Corporation, together with its subsidiaries, operates as a medical technology company worldwide. [BCS]
You May Also Be Interested In
- Stryker completes first surgery using FDA-cleared Apple Vision Pro app
- Aon Corp (AON) PT Lowered to $360 at BMO Capital
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
Create E-mail Alert Related Categories
Analyst Comments, Insiders' BlogRelated Entities
Soleil SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
